South Africa: SA's First Successful Genome Sequencing of a Local SARS-CoV-2 Sample Will Help Global Fight Against the Disease

(file photo).
analysis

South Africa's first successful genome sequencing of a locally collected sample of the SARS-CoV-2 virus is now being added to an international database to help better understand the disease.

Knowing the enemy of Covid-19 from a genetic perspective adds to understanding the puzzle of the virus that's killed more than 70,600 people around the world.

Yesterday (Monday 6 April), South African researchers announced in a report the successful genome sequencing of a local sample of SARS-CoV-2, the virus that's given rise to the Covid-19 pandemic.

Scientists at the NICD (National Institute of Communicable Diseases) together with colleagues at the South African National Bioinformatics Institute (Sanbi) at the University of the Western Cape were able to collect, analyse, and sequence the virus sample collected from the nose and throat of a patient in KwaZulu-Natal. The patient had returned to South Africa from a trip to Italy at the beginning of March.

This is South Africa's first genetic fingerprint of a locally analysed virus sample to be added to the Global Initiative on Sharing All Influenza Data (GISAID) records. Currently, there are about 4,000 SARS-COV-2 genetically sequenced virus samples in the database. Each addition boosts this still relatively small number of samples,...

More From: Daily Maverick

Don't Miss

AllAfrica publishes around 800 reports a day from more than 140 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.